Bay Area

March 27, 2024:  The Expanding Role of Pharma in our Ecosystem

September 28, 2023:  Implications of the IRA

  Dina Lynch, VP Market Access & Managed Care, Alzheon 

  Jason Punwani, Partner, Abingworth

  Katie McCarthy, Chief Innovation Officer, Halloran Consulting Group

  Leigh Ann Bruhn, EVP Value & Access, Syneos Health

  Moderated by Mark Spring, Managing Partner, Danforth Advisors

April 25, 2023:  Development & Manufacturing Challenges of Cell & Gene Therapies

   Barbra Sasu, CSO, Allogene

   David Schaffer, Director, Bakar BioEnginuity Hub & Bakar Labs

   Faraz Siddiqui, SVP, Manufacturing Operations, IGM Biosciences

   Julien Meissonnier, CSO, Catalent Pharma Solutions

   Nicole Paulk, Assistant Professor, UCSF

  Moderated by Chris Mason, Co-founder & former CSO, AVROBIO

September 8, 2022:  Current & Future State of M&A

   Darcy Mootz, Head, Amunix Pharmaceuticals

   Jay Stamatis, VP & Head of BD & Acquisitions, AbbVie

   Julianne Averill, CFO consultant, Danforth Advisors

   Lori Hu, Managing Director, Vertex Ventures HC

   Moderated by Samina Bari, Strategic Business Advisor, Cayuga Biotech

May 24, 2022:  Status of the Industry

   Anne Longmire, VP, JP Morgan

   Brent Vaughan, CEO, Cognito Therapeutics

   Mike Guerra, CEO, CA Life Sciences

   Shelley Chu, Partner, Lightspeed Venture Partners

   Moderated by Ben Conway, consultant, Danforth Advisors